α-D-Xyl-(1→6)-[α-D-Xyl-(1→6)-β-D-Glc-(→4)]-β-D-Glc

α-D-xylopyranosyl-(1→6)-[α-D-xylopyranosyl-(1→6)-β-D-glucopyranosyl-(→4)]-β-D-glucopyranose

HHXODKCLMMLNCM-ABVJEWOGSA-N CHEBI:137466 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: HHXODKCLMMLNCM-ABVJEWOGSA-N
InChI Key: HHXODKCLMMLNCM-ABVJEWOGSA-N
IUPAC name: α-D-xylopyranosyl-(1→6)-[α-D-xylopyranosyl-(1→6)-β-D-glucopyranosyl-(→4)]-β-D-glucopyranose
Preferred name: α-D-Xyl-(1→6)-[α-D-Xyl-(1→6)-β-D-Glc-(→4)]-β-D-Glc
INN name: —
Synonym: α-D-xylosyl-(1→6)-[α-D-xylosyl-(1→6)-β-D-glucosyl-(→4)]-β-D-glucose
ChEBI: CHEBI:137466

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide

Observed in differential profiles

Control_vs_OXPA_Treatment